Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 56Lung Neoplasms 29Triple Negative Breast Neoplasms 13Breast Neoplasms 13Ovarian Neoplasms 12Endometrial Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Small Cell Lung Carcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 11Neoplasms 10Fallopian Tube Neoplasms 10Neoplasm Metastasis 8Colorectal Neoplasms 5Adenocarcinoma of Lung 5Carcinoma 4Pancreatic Neoplasms 3Oropharyngeal Neoplasms 3Melanoma 3Lung Diseases 3Esophageal Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Thoracic Neoplasms 2Sarcoma 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Rectal Neoplasms 2Prostatic Neoplasms 2Pathologic Complete Response 2Non-squamous Non-small Cell Lung Cancer 2

Interventions

Radiotherapy 5Oxaliplatin 5Nivolumab 5Fluorouracil 5Cetuximab 5Leucovorin 4Magnetic Resonance Spectroscopy 3Bevacizumab 3sintilimab 2pembrolizumab 2fludarabine 2encorafenib 2aldesleukin 2Tomography, X-Ray Computed 2Specimen Handling 2Pemetrexed 2Magnetic Resonance Imaging 2Irinotecan 2Gemcitabine 2Folfox protocol 2Electrocardiography 2Drug Therapy 2Dexamethasone 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Biopsy 2ulixertinib 1trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Rectal Neoplasms × Carboplatin × 30 days × Clear all
NCT06607185 2026-05-26

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Eli Lilly and Company

Phase 1 Active not recruiting
750 enrolled
GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06704724 2026-05-22

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Pfizer

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡